US2011160459A1PendingUtilityA1

5-aryl-4,5-dihydro-(1h)-pyrazolines as cannabinoid cb1 receptor agonists

45
Assignee: SOLVAY PHARM BVPriority: Sep 20, 2007Filed: Mar 8, 2011Published: Jun 30, 2011
Est. expirySep 20, 2027(~1.2 yrs left)· nominal 20-yr term from priority
C07D 405/12C07C 235/80C07C 2602/42C07D 417/12A61P 25/28C07D 409/04C07D 401/04C07D 403/12C07D 231/06C07D 409/12A61P 25/00C07D 401/12
45
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed to 5-(hetero)aryl-4,5-dihydro-(1H)-pyrazole (pyrazoline) derivatives as cannabinoid CB 1 receptor agonists, to pharmaceutical compositions comprising these compounds, to methods for their syntheses, methods for preparing novel intermediates useful for their syntheses, and methods for preparing compositions. The invention also relates to the uses of such compounds and compositions, administered to patients to achieve a therapeutic effect in disorders in which CB 1 receptors are involved, or that can be treated via manipulation of those receptors. Compounds of the present invention include compounds of formula (I): wherein the substituents have the definitions given in the specification.

Claims

exact text as granted — not AI-modified
1 - 10 . (canceled) 
     
     
         11 . A compound of formula (Va): 
       
         
           
           
               
               
           
         
       
       or a tautomer, stereoisomer, N-oxide, isotopically-labelled analogue, or a pharmacologically acceptable salt of any of the foregoing, 
       wherein:
 R 1  is chosen from:
 C 3-10  linear alkyl, C 4-10  branched alkyl, C 4-10  alkenyl, C 4-10  alkynyl, C 3-10 -heteroalkyl, C 5-8 -cycloalkyl-C 1-5 -alkyl, and C 5-8 -heterocycloalkyl-C 1-5 -alkyl, each of which may be optionally substituted with 1-5 substituents, wherein the substituents are the same or different, and are chosen from methyl, ethyl, hydroxy, amino, cyano and fluoro, 
 aryl-C 1-3 -alkyl, heteroaryl-C 1-3 -alkyl, aryl-C 1-3 -heteroalkyl, and heteroaryl-C 1-3 -heteroalkyl, wherein the aryl or heteroaryl groups are optionally substituted with 1-5 substituents Y, wherein each Y is the same or different, and is chosen from C 1-3 -alkyl, C 1-3 -alkoxy, hydroxy, halogen, trifluoromethyl, trifluoromethylthio, trifluoromethoxy, nitro, amino, mono- or dialkyl (C 1-2 )-amino, mono- or dialkyl (C 1-2 )-amido, (C 1-3 )-alkyl sulfonyl, dimethylsulfamido, C 1-3 -alkoxycarbonyl, carboxyl, trifluoromethylsulfonyl, cyano, carbamoyl, sulfamoyl, phenyl, and acetyl, and 
 2-cyano-ethyl; 
 
 R 2  is chosen from aryl and heteroaryl, each of which may be optionally substituted with 1-5 substituents Y as defined above; 
 R 5  is chosen from hydrogen and C 1-2  alkyl, optionally substituted with 1-3 fluorine atoms; and 
 R 6  is chosen from hydrogen and C 1-2  alkyl, optionally substituted with 1-3 fluorine atoms; and 
 R 8  is chosen from chloro and OR 7 , where R 7  is C 1-3  alkyl; 
 
       provided that if R 2  is phenyl and R 1  is benzyl, then R 7  is not ethyl. 
     
     
         12 . A compound of formula (VI): 
       
         
           
           
               
               
           
         
       
       or a sodium, potassium, lithium, or cesium salt thereof, 
       wherein:
 R 1  is chosen from:
 C 3-10  linear alkyl, C 4-10  branched alkyl, C 4-10  alkenyl, C 4-10  alkynyl, C 3-10 -heteroalkyl, C 5-8 -cycloalkyl-C 1-5 -alkyl, and C 5-8 -heterocycloalkyl-C 1-5 -alkyl, each of which may be optionally substituted with 1-5 substituents, wherein the substituents are the same or different, and are chosen from methyl, ethyl, hydroxy, amino, cyano and fluoro, 
 aryl-C 1-3 -alkyl, heteroaryl-C 1-3 -alkyl, aryl-C 1-3 -heteroalkyl, and heteroaryl-C 1-3 -heteroalkyl, wherein the aryl or heteroaryl groups are optionally substituted with 1-5 substituents Y, wherein each Y is the same or different, and is chosen from C 1-3 -alkyl, C 1-3 -alkoxy, hydroxy, halogen, trifluoromethyl, trifluoromethylthio, trifluoromethoxy, nitro, amino, mono- or dialkyl (C 1-2 )-amino, mono- or dialkyl (C 1-2 )-amido, (C 1-3 )-alkyl sulfonyl, dimethylsulfamido, C 1-3 -alkoxycarbonyl, carboxyl, trifluoromethylsulfonyl, cyano, carbamoyl, sulfamoyl, phenyl, and acetyl, and 
 2-cyano-ethyl; 
 
 R 2  is chosen from aryl and heteroaryl, each of which may be optionally substituted with 1-5 substituents Y as defined above; 
 R 5  is chosen from hydrogen and C 1-2  alkyl, optionally substituted with 1-3 fluorine atoms; and 
 R 6  is chosen from hydrogen and C 1-2  alkyl, optionally substituted with 1-3 fluorine atoms; 
 
       provided that if R 2  is phenyl then R 1  is not benzyl. 
     
     
         13 . (canceled)

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.